Anaesthetic practice and mortality in Scotland compared to England from 1847 to 1914.

Anaesth Intensive Care

Science, Technology and Innovation Studies, School of Social and Political Science, University of Edinburgh, Edinburgh, UK.

Published: February 2025

In the second half of the nineteenth century and up to the First World War, anaesthetic practice in Scotland differed markedly from that in England. Chloroform was invariably used in Scotland with apparent disregard for reports of deaths under its influence. By contrast, in England concern about chloroform deaths, which were subject to inquests there, led to ether often being chosen instead. This article examines the different interpretations and handling of chloroform deaths in the two countries, drawing on the medical journals of the period and archived documents. Quite symmetrical claims were made. Whereas in England the danger of chloroform was perceived to be an inherent property of the agent itself, in Scotland the blame was thrown on a timid method of administration. The interpretation in Scotland was supported by a network of doctors who promoted chloroform as effective, safe and easy to administer; manufacturers who had monopoly of its manufacture; and legal practitioners who were uninterested in investigating anaesthetic deaths. Although the reporting of anaesthetic deaths was flawed in England, underreporting was far worse in Scotland. The fear of anaesthetic deaths in England allowed the seeds of specialisation in anaesthesia to germinate, whereas in Scotland the downplaying of anaesthetic risk obviated the notion of such specialisation.

Download full-text PDF

Source
http://dx.doi.org/10.1177/0310057X241304419DOI Listing

Publication Analysis

Top Keywords

anaesthetic deaths
12
anaesthetic practice
8
chloroform deaths
8
scotland
7
anaesthetic
6
england
6
deaths
6
chloroform
5
practice mortality
4
mortality scotland
4

Similar Publications

Surgery in patients aged ≥ 80 years: mortality and recovery in a nationwide cohort study.

Anaesthesia

March 2025

Section of Anesthesiology and Intensive Care Medicine, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.

Introduction: As the global population ages, the demand for surgical interventions in older adults is rising. Older patients face increased risks due to age-related physiological changes and comorbidities, making surgery and postoperative care challenging. This study aimed to assess short- and long-term mortality, as well as patient-centred outcomes such as days alive and at home 30 and 90 days after surgery, in patients aged ≥ 80 y undergoing surgical procedures.

View Article and Find Full Text PDF

Introduction Pulmonary hypertension (PH) significantly influences chronic obstructive pulmonary disease (COPD) outcomes by exacerbating symptoms, increasing the frequency and severity of exacerbations, and contributing to higher hospitalization rates and mortality. Ultrasound assessment of mean pulmonary arterial pressure (PAPm) may contribute to the severity assessment of COPD. This study aims to assess the one-year prognostic value of PAPm at rest and after exercise in COPD patients.

View Article and Find Full Text PDF

Background: Continuous and wireless vital sign (VS) monitoring on hospital wards is superior to intermittent VS monitoring at detecting VS abnormalities; however, the impact on clinical outcomes remains to be confirmed. A recent propensity-matched study of primary surgical patients found decreased odds of intensive care unit (ICU) admission and mortality in patients receiving continuous monitoring. Primary surgical patients are inherently different from their medical counterparts who typically have high morbidity, including frailty.

View Article and Find Full Text PDF

Background And Objectives: Evidence suggests that the receipt of general anesthesia may be associated with an increased risk of epilepsy compared with neuraxial (i.e., spinal or epidural) anesthesia.

View Article and Find Full Text PDF

Dual mRNA nanoparticles strategy for enhanced pancreatic cancer treatment and β-elemene combination therapy.

Proc Natl Acad Sci U S A

March 2025

Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines, Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China.

Pancreatic ductal adenocarcinoma (PDAC) is notoriously immune-resistant, limiting the clinical efficacy of single-agent immune modulators and thereby necessitating the exploration of multimodal immunotherapy combinations. Traditional approaches combining conventional immune checkpoint inhibitors with neoantigen vaccines have shown some promise in treating PDAC but are often compromised by intratumoral T lymphocyte exhaustion and systemic toxicity. Hence, novel approaches are needed to address these challenges.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!